Journal of Cerebral Blood Flow and Metabolism 1999-02-01

Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia.

B Spinnewyn, S Cornet, M Auguet, P E Chabrier

Index: J. Cereb. Blood Flow Metab. 19(2) , 139-43, (1999)

Full Text: HTML

Abstract

Both nitric oxide synthase (NOS) inhibitors and free radical scavengers have been shown to protect brain tissue in ischemia-reperfusion injury. Nitric oxide and superoxide anion act via distinct mechanisms and react together to form the highly deleterious peroxynitrite. Therefore the authors examined the effects and the interaction between the NOS inhibitor, NG nitro-L-arginine (LNA) and the antioxidant/superoxide scavenger, di-tert-butyl-hydroxybenzoic acid (DtBHB) in the rat submitted to 2 hours of middle cerebral artery occlusion. Posttreatment was initiated 4 hours after the onset of ischemia and infarct volume was measured at 48 hours. The dose-related effect of LNA resulted in a bell-shaped curve: 15, 56, 65, and 33% reduction of total infarct for 0.03, 0.1, 0.3, and 1 mg/kg (intravenously [IV]) respectively and 11% increase in infarct volume for 3 mg/kg (IV). Whereas DtBHB (20 mg/kg; intraperitoneally [IP]) was ineffective, the dose of 60 mg/kg produced 65% protection in infarct volume. The combination of a subthreshold dose of LNA (0.03 mg/kg; IV) and DtBHB (20 mg/kg; IP) resulted in significant reduction (49%) in infarct volume. These results show that LNA and DtBHB act synergistically to provide a consistent neuroprotection against ischemic injury when administered 4 hours after ischemia. This suggests that nitric oxide and free radicals are involved and interact in synergy in ischemia-reperfusion injury.


Related Compounds

Related Articles:

Human exposure assessment to a large set of polymer additives through the analysis of urine by solid phase extraction followed by ultra high performance liquid chromatography coupled to tandem mass spectrometry.

2015-12-04

[J. Chromatogr. A. 1423 , 111-23, (2015)]

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies.

2012-01-01

[Drug Des. Devel. Ther. 6 , 323-39, (2012)]

Determination of synthetic phenolic antioxidants and their metabolites in water samples by downscaled solid-phase extraction, silylation and gas chromatography-mass spectrometry.

2010-10-08

[J. Chromatogr. A. 1217(41) , 6428-35, (2010)]

Novel compounds designed as antistress agents.

2009-11-26

[J. Med. Chem. 52 , 7315-8, (2009)]

Disposition of single oral doses of butylated hydroxytoluene in man and rat.

1989-12-01

[Food Chem. Toxicol. 27(12) , 765-72, (1989)]

More Articles...